Olon Group is a global leader in the development and production of active pharmaceutical ingredients for CDMO and Generics, a reliable and preferential partner to the pharmaceutical, biotech and specialty ingredients markets.
They challenge and innovate the way to deliver science to improve health of human beings. Their competitiveness is based on creative ideas and pathways for prompt and sustainable solutions in life science industry.
Since the foundation, Olon has achieved a continuous development that drives their economic growth and global expansion, with the mission of becoming the promoters of a new perspective through which to frame all of the chemical sector: an ambitious vision built on the highest standards of quality, on a constant innovation and technology process, on the will to be a persistent enabler of capabilities, and overall on environmental sustainability.
Thanks to this approach, to the trust found on their reliability, and to the full accountability along the entire process from early phase to commercialization, they have formed over strong ties with all their partners over the years.